Tobin P. Sullivan

Business & Technology: counsel for businesses ranging from start-ups, to pre-IPO companies, to global public companies in a variety of corporate transactions and business matters, including national and cross-border mergers and acquisitions, venture capital equity financings, corporate governance matters, public company reporting and SEC compliance.

Private Equity & Venture Capital: transactional counsel to leading private equity and venture capital firms in software and technology, biotech, HealthIT, healthcare services and telecommunications on minority and growth equity investments, buyouts and recapitalizations.

Business & Technology Engagements:

• Represented OneWeb in a $1.25 billion financing round led by SoftBank, Qualcomm Technologies and Grupo Salinas.
• Represented Datawatch Corporation (Nasdaq: DWCH) in its $176 million sale to Altair Engineering (Nasdaq: ALTR).
• Represented Examity Inc. in securing a $90 million growth equity investment from private equity firm Great Hill Partners.
• Represented BioRx in its $350 million sale to Diplomat Pharmacy (NYSE: DPLO).
• Representation of Cyteir Therapeutics in equity financing by Venrock Partners, Celgene, Lightstone Ventures, and DROIA Oncology Venture.
• Represented U.S. public life sciences company in strategic acquisition of privately held life sciences company based in Switzerland.
• Represented Cosman Medical in sale to Boston Scientific (NYSE: BSX).
• General counsel to satellite broadband company, including advising on its $1+ billion equity financing led by SoftBank.
• Represented FP Resources USA Inc. in the take-private acquisition of The First Marblehead Corporation (NYSE: FMD).
• Represented Datawatch Corporation (NASDAQ: DWCH) in its acquisition of Angoss Software Corporation, a Canadian data analytics company.
• Represented Nasdaq-listed life sciences company in $75 million follow-on offering.

Private Equity & Venture Capital Engagements:

• Represented leading private equity funds in growth equity investments in biotech companies.
• Represented leading private equity fund in its investment in an omni-channel retail software supplier and the company’s subsequent sale to a private-equity buyer.
• Represented private equity fund in $200+ million leveraged buyout of specialty hardware component manufacturer.
• $220+ million sale of private-equity backed fiber-optic bandwidth infrastructure services provider operating in the Northeast United States.
• Represented medical device company and its private equity sponsor in $33 million sale to Irish-based public company.
• Representation of Texas-based private equity fund in its growth equity investment in an oil and gas services company based in Canada.

“Funding Gap for Life Science Companies Is Still a Problem,” co-author, Life Sciences Law360, September 2013.

Tobin is actively involved in corporate pro bono work for the Center for Women & Enterprise and has represented pro bono clients from the Lawyer’s Clearinghouse — Massachusetts Legal Clinic for the Homeless. He is currently a member of the Boston Bar and American Bar Associations. He currently serves on Choate’s Hiring Committee.